Health-Care M&A: 2016 Market Report Card

The transcript discusses market trends from 2015 to 2016, highlighting a slowdown in big deals. It explores the healthcare market, noting consistent activity and recent significant deals like Medivation with Pfizer. The biotech industry's evolution is examined, emphasizing a shift towards science-focused deals and the maturity of the sector. Future trends in pharmaceuticals are predicted, with oncology and orphan diseases as key areas, and potential growth in treatments for degenerative diseases like Alzheimer's.

What trends are observed in the oncology market and its potential for future growth?

What are the anticipated future areas of focus for pharma and biotech companies according to demographic trends?